USMLE Step 1 Congenital and Genetic Syndromes
USMLE Step 1 Congenital and Genetic Syndromes
Mastering the presentation of congenital and genetic syndromes is a cornerstone of USMLE Step 1 success. These conditions test your integrated knowledge of embryology, genetics, pathophysiology, and clinical medicine, appearing frequently in vignettes that describe patients with distinct physical stigmata or developmental delays. A systematic approach to their hallmark features, inheritance patterns, and associated risks will enable you to answer these questions confidently and efficiently.
Classic Syndromes: From Trisomies to Sex Chromosome Aneuploidies
This category includes some of the most commonly tested conditions, where the clinical presentation is directly tied to a specific chromosomal abnormality.
Down syndrome (Trisomy 21) is the most common viable chromosomal disorder. Its features result from the presence of an extra chromosome 21. Key clinical findings include intellectual disability, characteristic facies (epicanthal folds, flat nasal bridge, protruding tongue), single palmar crease, and congenital heart defects—most notably atrioventricular septal defect (AVSD). Associated risks include acute lymphoblastic leukemia (ALL), early-onset Alzheimer disease (due to amyloid precursor protein gene on chromosome 21), and duodenal atresia (seen as a "double bubble" sign on imaging).
Turner syndrome (45, X) results from the complete or partial absence of one X chromosome in a phenotypic female. The classic presentation is a girl with short stature, primary amenorrhea due to streak ovaries, and a webbed neck. Congenital heart defects are common, particularly coarctation of the aorta and bicuspid aortic valve. Patients also have a wide chest with widely spaced nipples (shield chest) and may develop lymphedema of the hands and feet in the neonatal period. Importantly, intelligence is typically normal.
Klinefelter syndrome (47, XXY) is the most common sex chromosome disorder in males. Patients are tall with long limbs (eunuchoid body habitus) and present with infertility and small, firm testes. They often have gynecomastia and may exhibit learning disabilities or behavioral problems. Hormonally, they show increased follicle-stimulating hormone (FSH) and decreased testosterone levels.
Mendelian and Trinucleotide Repeat Disorders
These syndromes follow classic inheritance patterns and involve specific gene mutations, making them prime targets for Step 1 questions testing your grasp of genetics.
Fragile X syndrome is the most common inherited cause of intellectual disability. It is an X-linked dominant disorder with trinucleotide repeat expansion (CGG) in the FMR1 gene, which demonstrates anticipation (worsening severity in subsequent generations). Males are more severely affected and present with intellectual disability, macroorchidism (large testes), long face, large ears, and autistic behaviors. Females may be less severely affected carriers.
Cystic fibrosis is a classic autosomal recessive disorder caused by mutations in the CFTR gene on chromosome 7, most commonly . Defective chloride channels lead to thick, viscous secretions. The Step 1 hallmarks are chronic lung infections (especially with Pseudomonas aeruginosa and Staphylococcus aureus), pancreatic insufficiency (fatty stools, deficiency of fat-soluble vitamins A, D, E, K), and infertility in males due to congenital bilateral absence of the vas deferens. Newborns may present with meconium ileus.
Marfan syndrome is an autosomal dominant disorder of fibrillin-1 (FBN1) affecting connective tissue. The classic triad involves the musculoskeletal (tall, long limbs, arachnodactyly, pectus deformity), ocular (ectopia lentis—lens dislocation upward), and cardiovascular systems. The most life-threatening complication is aortic root dilation leading to aortic dissection and aortic regurgitation. Mitral valve prolapse is also common.
Ehlers-Danlos syndrome (EDS) encompasses a group of disorders characterized by hyperextensible skin, hypermobile joints, and easy bruising/tissue fragility. The classic, most common type is the hypermobility type. For Step 1, the most high-yield subtype is vascular EDS (type IV), caused by a defect in type III collagen (COL3A1). These patients are at high risk for spontaneous rupture of the bowel, uterus, and large arteries—a favorite exam point.
Neurofibromatosis type 1 (NF1, von Recklinghausen disease) is an autosomal dominant disorder with near 100% penetrance but variable expressivity. Diagnosis is clinical, based on meeting two or more criteria: café-au-lait spots (≥6, >5mm in prepubertal individuals), axillary/inguinal freckling, Lisch nodules (harmless iris hamartomas), neurofibromas, and bony lesions. Key associations include optic pathway glioma and pheochromocytoma. Remember the mnemonic for features: CALF SPOT (Café-au-lait, Axillary freckling, Lisch nodules, Fibromas, Scoliosis, Pheochromocytoma, Optic glioma, Tibial pseudarthrosis).
Genetic Principles, Testing, and Step 1 Strategy
Understanding the tools and concepts behind the diagnoses is as important as memorizing the syndromes themselves.
Inheritance pattern determination is a frequent question goal. Look for clues in the vignette:
- Autosomal Dominant: Vertical transmission, affects both sexes equally, every affected person has an affected parent (unless de novo mutation).
- Autosomal Recessive: Horizontal pattern (siblings affected), parents are typically asymptomatic carriers, associated with consanguinity.
- X-Linked Recessive: Skips generations, affects males almost exclusively, passed from carrier female to affected son.
- X-Linked Dominant (e.g., Fragile X): Affects both sexes, but males are often more severe; no male-to-male transmission.
Genetic testing methods you must know:
- Karyotype: Best for large-scale abnormalities like aneuploidies (Down, Turner, Klinefelter) and large deletions/translocations. Requires cell culture.
- FISH (Fluorescence In Situ Hybridization): Used for targeted analysis of specific chromosomes or regions (e.g., confirming microdeletions like DiGeorge/22q11.2).
- DNA Microarray/Comparative Genomic Hybridization (CGH): First-line test for developmental delay/intellectual disability of unknown cause. Detects copy number variants (microdeletions/duplications).
- PCR and DNA Sequencing: Used for diagnosing disorders with known specific gene mutations (e.g., CFTR in cystic fibrosis, FBN1 in Marfan).
Genetic counseling concepts revolve around risk assessment. For autosomal recessive disorders with carrier parents, the risk of an affected child is 1 in 4 (25%) with each pregnancy. Be comfortable with basic Punnett squares. Remember that anticipation (earlier onset or increased severity in successive generations) is a hallmark of trinucleotide repeat disorders like Fragile X, Huntington disease, and myotonic dystrophy.
Common Pitfalls
- Confusing Marfan and Homocystinuria: Both can present with tall stature, ectopia lentis, and long limbs. The critical differentiator is the direction of lens dislocation: upward in Marfan, downward in homocystinuria. Furthermore, homocystinuria is autosomal recessive, associated with intellectual disability and thrombotic events (due to hypercoagulability), not aortic dissection.
- Misidentifying Inheritance Patterns in X-Linked Disorders: A common trap is seeing an affected male and assuming autosomal recessive inheritance. If the condition only appears in males across generations and is passed through unaffected females, think X-linked recessive. If females are also affected (often less severely), consider X-linked dominant.
- Overlooking the Most Lethal Complication: For many syndromes, the presenting complaint in a vignette may be benign, but the question is testing if you know the greatest risk. For Marfan, it’s aortic dissection. For vascular EDS, it’s spontaneous arterial or hollow organ rupture. For Turner, it’s coarctation of the aorta. Always ask yourself, "What is the most dangerous thing I need to screen for or prevent in this patient?"
- Selecting the Wrong First-Line Genetic Test: Using karyotype for a child with global developmental delay is outdated. The current first-line test is DNA microarray (CGH). Reserve karyotype for suspected aneuploidy based on dysmorphic features (e.g., suspicion of trisomy 21) or multiple miscarriages (to detect balanced translocations in a parent).
Summary
- Chromosomal Disorders: Down (Trisomy 21, AVSD, ALL), Turner (45,X, short stature, coarctation), and Klinefelter (47,XXY, tall, small testes, gynecomastia) syndromes are defined by specific aneuploidies and their corresponding clinical stigmata.
- Mendelian & Repeat Disorders: Key conditions include Fragile X (X-linked dominant, CGG repeats, macroorchidism), cystic fibrosis (AR, CFTR, lung/pancreas disease), Marfan (AD, fibrillin-1, ectopia lentis up, aortic dissection), vascular EDS (AD, COL3A1, arterial rupture), and NF1 (AD, café-au-lait spots, Lisch nodules, optic glioma).
- Testing Strategy: Use karyotype for aneuploidy, DNA microarray for idiopathic developmental delay/intellectual disability, and targeted sequencing for known specific gene mutations.
- Inheritance Clues: Analyze the pedigree pattern. Lack of male-to-male transmission is a cardinal sign of an X-linked disorder.
- Exam Focus: Step 1 vignettes often present a collection of dysmorphic features—link the physical findings to the underlying genetic defect and its most critical complication.